Summary
Recent studies have indicated that GM2-1, a pancreatic islet monosialo-ganglioside, is an islet-specific component whose expression is metabolically regulable and represents one of the target antigens of cytoplasmic islet cell antibodies. In the present study we aimed to biochemically characterize this molecule using a panel of biochemical techniques including gas chromatography, thin layer chromatography, enzymatic digestion and mass spectrometry. GM2-1 ganglioside was extracted from human pancreas and purified by thin-layer chromatography. Fatty acids in the ceramide (the hydrophobic portion of the molecule), identified by gas chromatography ranged from C16:1 to C24:1. The oligosaccharide chain was enzymatically digested by the sequential application of various exoglycosidases (neuraminidase followed by Β-galactosidase, followed by Β-hexosaminidase) and characterized by gas chromatography identification of the liberated sugars. The following structure was deducted from enzymatic studies and confirmed by mass spectrometry analysis: N-acetyl neuraminic acid-galactose-galactosamine-galactosamine-glucose-ceramide. This is a novel ganglioside structure, not yet described, which shares characteristics with a neuronal glycolipid autoantigen: the LM1 ganglioside. Both GM2-1 and LM1 have a single sialic acid residue in the terminal position, the same migration position on thin layer chromatography and the same number of carbohydrate moieties. In conclusion, we have characterized a novel islet-specific ganglioside molecule with unusual characteristics, such as the terminal sialic acid and the galactosamine residues, which may facilitate both its anti-genicity and its involvement in beta-cell autoimmunity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- ICA:
-
islet cell antibodies
- GC:
-
gas chromatography
- TLC:
-
thin layer chromatography
- MS:
-
mass spectrometry
- amu:
-
atomic mass units
- NANA:
-
N-acetyl-neuraminic acid
- HPTLC:
-
high performance thin layer chromatography
References
Hakomori SI (1981) Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Ann Rev Biochem 50: 733–764
Atkinson MA, MacLaren NK (1993) Islet cell autoantigens in insulin dependent diabetes. J Clin Invest 92: 1608–1616
Genovese S, Bonifacio E, McNally JM et al. (1992) Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385–389
Atkinson MA, Kaufman DL, Campbell L, Tobin AJ, MacLaren NK (1993) Islet cell cytoplasmic antibody reactivity to glutamate decarboxylase in insulin dependent diabetes. J Clin Invest 91: 350–356
Colman PG, Nayak RC, Campbell IL, Eisenbarth GS (1988) Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37: 645–652
Dotta F, Colman PG, Lombardi D et al. (1989) Ganglioside expression in human pancreatic islets. Diabetes 38: 1478–1483
Dotta F, Peterson LB, Previti M et al. (1992) Pancreatic islet ganglioside expression in non obese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune Β cell destruction. Endocrinology 130: 37–42
Gillard B, Thomas JW, Nell LJ, Marcus DM (1989) Antibodies against ganglioside GT3 in sera of patients with type 1 diabetes mellitus. J Immunol 142: 3826–3832
Macher BA, Klock JC (1980) Isolation and characterization of neutral glycosphingolipids of human neutrophils. J Biol Chem 255: 2092–2096
Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L (1991) Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol 238: 75–79
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dotta, F., Previti, M., Lenti, L. et al. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 38, 1117–1121 (1995). https://doi.org/10.1007/BF00402184
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402184